Bluesight Launches Redesigned 340BCheck Platform As Compliance Demands Intensify

Bluesight, which offers hospital intelligence solutions, launched a redesigned 340BCheck software platform: a compliance command center built to help covered entities maintain compliance and defend their 340B programs. The 340B Drug Pricing Program is a U.S. federal program that requires pharmaceutical companies to sell outpatient drugs at steep discounts (20% to 50% off) to health care organizations that care for low-income, uninsured, and rural consumers.

340BCheck builds on technology originally developed by Sectyr and acquired by Bluesight in 2024. Since the acquisition, Bluesight has expanded the platform's capabilities, including a 100% transaction audit introduced in 2025, culminating . . .